FTH1 and neoplasm: Similarly, in the context of tumor immunotherapy resistance, FTH1 contributes to the development of an inhibitory tumor immune microenvironment, which facilitates resistance to anti-PD-1/L1 immunotherapy by regulating immune cell infiltration and activation [17].